Digoxin Induced Dissolution of CTC Clusters

NCT03928210 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Circulating Tumor Cells (CTCs)

Interventions

DRUG: Digoxin

Sponsor

University Hospital, Basel, Switzerland

Collaborators

[object Object]